Plasma Asymmetric Dimethylarginine as a Biomarker of Disease Severity and Therapeutic Response in Neonatal Persistent Pulmonary Hypertension: An Observational Prospective Case-Control Study.
- DOI
- 10.7417/ct.2026.2039
- Published
- 2026 May-Jun
- Container
- La Clinica terapeutica
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.7417/ct.2026.2039,
title = {Plasma Asymmetric Dimethylarginine as a Biomarker of Disease Severity and Therapeutic Response in Neonatal Persistent Pulmonary Hypertension: An Observational Prospective Case-Control Study.},
author = {Abdou RM and El Wakeel MA and El-Kassas GM and Ali WH and Ahmed HM and Agha M and Abdel Fatah MAA and Abdelghany RS and Madbouly KSEF and Mohamad HB and Hassan IS and Ahmed MAM and Okda HT and Ismail HAM},
year = {2026},
journal = {La Clinica terapeutica},
doi = {10.7417/ct.2026.2039},
url = {https://doi.org/10.7417/ct.2026.2039}
}RIS
TY - JOUR TI - Plasma Asymmetric Dimethylarginine as a Biomarker of Disease Severity and Therapeutic Response in Neonatal Persistent Pulmonary Hypertension: An Observational Prospective Case-Control Study. AU - Abdou RM AU - El Wakeel MA AU - El-Kassas GM AU - Ali WH AU - Ahmed HM AU - Agha M AU - Abdel Fatah MAA AU - Abdelghany RS AU - Madbouly KSEF AU - Mohamad HB AU - Hassan IS AU - Ahmed MAM AU - Okda HT AU - Ismail HAM PY - 2026 JO - La Clinica terapeutica DO - 10.7417/ct.2026.2039 UR - https://doi.org/10.7417/ct.2026.2039 ER -
APA
RM, A., MA, E. W., GM, E., WH, A., HM, A., M, A., MAA, A. F., RS, A., KSEF, M., HB, M., IS, H., MAM, A., HT, O., & HAM, I. (2026). Plasma Asymmetric Dimethylarginine as a Biomarker of Disease Severity and Therapeutic Response in Neonatal Persistent Pulmonary Hypertension: An Observational Prospective Case-Control Study.. La Clinica terapeutica. https://doi.org/10.7417/ct.2026.2039
Source records
- pubmed · retrieved 2026-09-25T19:44:24.340Z